Ambev S.A. ADR (NYSE: ABEV) has experienced a decline in its stock price by 0.00 compared to its previous closing price of 2.08. However, the company has seen a gain of 0.48% in its stock price over the last five trading days. marketwatch.com reported 2024-06-21 that Consumer surveys in Canada and the U.S. show that alcohol consumption is down in areas where adults have the option to consume legal cannabis, Bernstein analyst Nadine Sarwat said in a research note on Friday.
Is It Worth Investing in Ambev S.A. ADR (NYSE: ABEV) Right Now?
The price-to-earnings ratio for Ambev S.A. ADR (NYSE: ABEV) is above average at 11.21x, Company’s 36-month beta value is 1.09.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 5 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ABEV is 15.75B, and currently, short sellers hold a 0.07% ratio of that floaft. The average trading volume of ABEV on June 21, 2024 was 15.69M shares.
ABEV’s Market Performance
ABEV’s stock has seen a 0.48% increase for the week, with a -10.34% drop in the past month and a -16.47% fall in the past quarter. The volatility ratio for the week is 2.23%, and the volatility levels for the past 30 days are at 2.29% for Ambev S.A. ADR The simple moving average for the past 20 days is -4.41% for ABEV’s stock, with a -16.86% simple moving average for the past 200 days.
Analysts’ Opinion of ABEV
Many brokerage firms have already submitted their reports for ABEV stocks, with Barclays repeating the rating for ABEV by listing it as a “Equal Weight.” The predicted price for ABEV in the upcoming period, according to Barclays is $3 based on the research report published on March 04, 2024 of the current year 2024.
ABEV Trading at -8.73% from the 50-Day Moving Average
After a stumble in the market that brought ABEV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.09% of loss for the given period.
Volatility was left at 2.29%, however, over the last 30 days, the volatility rate increased by 2.23%, as shares sank -9.13% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.18% lower at present.
During the last 5 trading sessions, ABEV rose by +0.97%, which changed the moving average for the period of 200-days by -24.82% in comparison to the 20-day moving average, which settled at $2.17. In addition, Ambev S.A. ADR saw -25.71% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ABEV
Current profitability levels for the company are sitting at:
- 0.22 for the present operating margin
- 0.49 for the gross margin
The net margin for Ambev S.A. ADR stands at 0.17. The total capital return value is set at 0.18. Equity return is now at value 17.26, with 10.77 for asset returns.
Based on Ambev S.A. ADR (ABEV), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at 6.81. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is 4.52.
Currently, EBITDA for the company is 23.56 billion with net debt to EBITDA at -0.36. When we switch over and look at the enterprise to sales, we see a ratio of 2.12. The receivables turnover for the company is 9.47for trailing twelve months and the total asset turnover is 0.6. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.99.
Conclusion
In a nutshell, Ambev S.A. ADR (ABEV) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
